+254.2%
MRNA vs MAS
+60.2%
+194.1%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | MAS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.9% | +0.1% | -1.0% | -0.9% |
| 7D | -3.8% | -1.8% | -1.9% | -2.5% |
| 30D | +16.4% | +23.6% | -7.2% | +1.1% |
| 3M | +310.6% | +12.4% | +298.1% | +281.4% |
| 6M | +370.3% | +21.9% | +348.4% | +314.7% |
| YTD | +743.3% | +36.1% | +707.2% | +586.9% |
| 1Y | +841.7% | +39.5% | +802.2% | +654.7% |
| All | +254.2% | +60.2% | +194.1% | +143.9% |
Cumulative growth
Daily Returns
Daily percentage return beside MAS.
Daily Out/Under-Performance
Portfolio return minus MAS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MAS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded MAS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling